Jaber Bertrand L, Rao Madhumathi, Guo Daqing, Balakrishnan Vaidyanathapuram S, Perianayagam Mary C, Freeman Richard B, Pereira Brian J G
Division of Nephrology, Tufts-New England Medical Center, Boston, MA 02111, USA.
Cytokine. 2004 Mar 7;25(5):212-9. doi: 10.1016/j.cyto.2003.11.004.
Although cytokines play a pivotal role in the inflammatory responses that mediate the severity of acute renal failure (ARF), the importance of pro- and anti-inflammatory cytokine gene promoter polymorphisms has been unexplored.
We prospectively evaluated the relationship of single nucleotide polymorphism in the promoter region of tumor necrosis factor alpha (TNF-alpha) and interleukin-10 (IL-10) to mortality in 61 patients with ARF requiring intermittent hemodialysis. Cytokine genotyping was performed on leukocytes using PCR techniques. Cox proportional-hazards regression analysis was used to explore these relationships.
The mean (+/-SD) APACHE II score was 24 +/- 7, MOF score 2 +/- 1, and 64% had sepsis. The TNF-alpha high producer genotype (-308 A-allele carrier) was associated with a higher risk of death after adjustment for the APACHE II score (HR=2.5; P=0.04), and the IL-10 intermediate/high producer genotype (-1082 G-allele carrier) was associated with a lower risk of death after adjustment for the MOF score (HR=0.36; P=0.03). Considering combinations of genotypes, the TNF-alpha high and IL-10 low producer genotype combination was associated with a approximately 6-fold increased risk of death compared to the TNF-alpha-low and IL-10 intermediate/high producer genotype combination, after adjustment for either APACHE II (P=0.004), MOF score (P=0.004) or sepsis (P=0.006).
TNF-alpha and IL-10 gene polymorphisms are related to the risk of death among patients with ARF who require dialysis. Larger studies are needed to confirm these relationships.
尽管细胞因子在介导急性肾衰竭(ARF)严重程度的炎症反应中起关键作用,但促炎和抗炎细胞因子基因启动子多态性的重要性尚未得到探索。
我们前瞻性评估了61例需要间歇性血液透析的ARF患者中肿瘤坏死因子α(TNF-α)和白细胞介素-10(IL-10)启动子区域单核苷酸多态性与死亡率的关系。使用PCR技术对白细胞进行细胞因子基因分型。采用Cox比例风险回归分析来探索这些关系。
平均(±标准差)急性生理与慢性健康状况评分系统(APACHE II)评分为24±7,多器官功能障碍评分(MOF)为2±1,64%的患者患有脓毒症。调整APACHE II评分后,TNF-α高产生基因型(-308 A等位基因携带者)与较高的死亡风险相关(风险比[HR]=2.5;P=0.04),调整MOF评分后,IL-10中等/高产生基因型(-1082 G等位基因携带者)与较低的死亡风险相关(HR=0.36;P=0.03)。考虑基因型组合,调整APACHE II(P=0.004)、MOF评分(P=0.004)或脓毒症(P=0.006)后,与TNF-α低和IL-10中等/高产生基因型组合相比,TNF-α高和IL-10低产生基因型组合的死亡风险增加约6倍。
TNF-α和IL-10基因多态性与需要透析的ARF患者的死亡风险相关。需要更大规模的研究来证实这些关系。